CA2578212A1 - Methodes favorisant la guerison de plaies - Google Patents

Methodes favorisant la guerison de plaies Download PDF

Info

Publication number
CA2578212A1
CA2578212A1 CA002578212A CA2578212A CA2578212A1 CA 2578212 A1 CA2578212 A1 CA 2578212A1 CA 002578212 A CA002578212 A CA 002578212A CA 2578212 A CA2578212 A CA 2578212A CA 2578212 A1 CA2578212 A1 CA 2578212A1
Authority
CA
Canada
Prior art keywords
growth factor
product
wound healing
wound
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002578212A
Other languages
English (en)
Inventor
Eli Wilner
Mathew Cohen (Deceased)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
POSNER SARI
Advanced Viral Research Corp
Original Assignee
POSNER SARI
Advanced Viral Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by POSNER SARI, Advanced Viral Research Corp filed Critical POSNER SARI
Publication of CA2578212A1 publication Critical patent/CA2578212A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CA002578212A 2004-08-27 2005-08-29 Methodes favorisant la guerison de plaies Abandoned CA2578212A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60532004P 2004-08-27 2004-08-27
US60/605,320 2004-08-27
PCT/US2005/030798 WO2006026604A2 (fr) 2004-08-27 2005-08-29 Méthodes favorisant la guérison de plaies

Publications (1)

Publication Number Publication Date
CA2578212A1 true CA2578212A1 (fr) 2006-03-09

Family

ID=36000687

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002578212A Abandoned CA2578212A1 (fr) 2004-08-27 2005-08-29 Methodes favorisant la guerison de plaies

Country Status (5)

Country Link
EP (1) EP1804817A4 (fr)
JP (1) JP2008511652A (fr)
AU (1) AU2005279921A1 (fr)
CA (1) CA2578212A1 (fr)
WO (1) WO2006026604A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528098B2 (en) 1996-10-22 2003-03-04 Advanced Viral Research Corp. Preparation of a therapeutic composition
UA101459C2 (uk) * 2009-09-29 2013-03-25 Юнайтед Технолоджіс Ут Аг Склад для догляду за порожниною рота, що містить людський рекомбінантний інтерлейкін-1
EA032501B9 (ru) 2013-04-18 2019-11-29 Qbiotics Ltd Способы и композиции для содействия заживлению острой раны и хронической раны
CN108339112B (zh) * 2016-12-30 2023-04-21 亚宝药业集团股份有限公司 一种用于促进创伤愈合、褥疮修复、术后应激性溃疡愈合的营养组合物
CN118121594B (zh) * 2024-05-06 2024-07-02 广州市朝利良生物科技有限公司 Eh-p006n在制备促进伤口愈合药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849196A (en) * 1996-10-07 1998-12-15 Immune Modulation Maximum Composition containing peptides and nucleic acids and methods of making same
US6528098B2 (en) * 1996-10-22 2003-03-04 Advanced Viral Research Corp. Preparation of a therapeutic composition
US6303153B1 (en) * 1996-10-22 2001-10-16 Advanced Viral Research Corp. Preparation of a therapeutic composition
US5902786A (en) * 1997-04-15 1999-05-11 Advanced Viral Research Corp. Treatment of basal cell carcinoma with product R, a peptide-nucleic acid preparation
US5807839A (en) * 1997-04-15 1998-09-15 Advanced Viral Research Corp. Method for stimulating red blood cell production
US7439234B2 (en) * 1997-04-15 2008-10-21 Advanced Viral Research Corporation Method for treating cancer patients undergoing chemotherapy
AU6968098A (en) * 1997-04-15 1998-11-11 Advanced Viral Research Corp. Topical treatment of skin diseases and eye afflictions
CN1251969A (zh) * 1997-04-15 2000-05-03 领先病毒研究公司 治疗乳头瘤病毒感染的方法
US20020107184A1 (en) * 1997-11-04 2002-08-08 Shalom Z. Hirschman Method for treating melanoma

Also Published As

Publication number Publication date
EP1804817A4 (fr) 2009-11-11
WO2006026604A2 (fr) 2006-03-09
AU2005279921A1 (en) 2006-03-09
WO2006026604A3 (fr) 2006-12-07
EP1804817A2 (fr) 2007-07-11
JP2008511652A (ja) 2008-04-17

Similar Documents

Publication Publication Date Title
US7858582B2 (en) Ophthalmic hGM-CSF preparation
KR20080100425A (ko) 조절된 혈액 조성물 및 이의 생산 방법
JPH05506673A (ja) 迅速な創傷の治癒を促進するためのｇｍ―ｃｓｆ及びｇ―ｃｓｆの使用
CA2578212A1 (fr) Methodes favorisant la guerison de plaies
US7645733B2 (en) Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
JP4880589B2 (ja) 創傷治癒のためのスピノシンの使用
CN112933214A (zh) 一种促进伤口愈合的组合物
BG63331B1 (bg) Лизозимен димер и състави, които го съдържат
RU2209074C2 (ru) Состав для лечения ожогов
Gültekin et al. Treatment of a Full-Thickness Skin Wound in Gluteal Region of the Vervet Monkey with Topical Insulin
AU2005332686B2 (en) Methods for providing palliative care with AVR118
US20150051147A1 (en) Methods for treating hidradenitis suppurativa
RU2739697C1 (ru) Способ профилактики послеродового эндометрита у коров
US20190321412A1 (en) Methods and compositions using dehydrated human amnion/chorion membrane allograft and amnionic membrane allograft suspensions for the treatment of hair loss
CN116036105A (zh) 一种治疗淋巴水肿的药物运用
CN116585457A (zh) 一种用于治疗难愈性创面的组合物及其制剂与应用
EP2089050A2 (fr) Utilisation de l'il-17b pour la cicatrisation des plaies
RU2152214C1 (ru) Способ лечения острого остеомиелита
RU2115428C1 (ru) Способ лечения иммуносупрессии при сепсисе у человека
TW202202145A (zh) 促進傷口癒合的有機鍺藥物及其使用方法
RU2202356C2 (ru) Способ стимуляции репаративных процессов длительно незаживающих ран и трофических язв
WO2007018846A2 (fr) Procedes permettant de reduire la formation de tissus cicatriciels
CN117617500A (zh) 一种适用于术后恢复的功能型配方粉及其制备方法和用法
TW202339762A (zh) 促進傷口癒合的有機鍺藥物及其使用方法
CN116036106A (zh) 一种治疗淋巴水肿的药物运用

Legal Events

Date Code Title Description
FZDE Dead